Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Biotech
Health
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Business
STAT+

Verily, Google’s life science spinout, picks up $800M investment from Singapore firm

  • Meghana Keshavan

By Meghana Keshavan Jan. 26, 2017

Reprints
Verily headquarters
Gideon Gil/STAT

Verily is amping up its expansion plan into Asia: The Google life sciences spinout said Thursday it’s getting $800 million from Singapore investment firm Temasek to broaden its commercial reach around the world.

Temasek, which set up an office in San Francisco last year, will gain a minority stake in Verily.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

Tags

Texas judge strikes down major Obamacare provision protecting preventive…
Texas judge strikes down major Obamacare provision protecting preventive care
Former J&J exec, an in-demand free agent, takes the…
Former J&J exec, an in-demand free agent, takes the helm at privately held FogPharma
Experts weigh in on potential health hazards posed by…
Experts weigh in on potential health hazards posed by chemicals in Ohio train derailment
FDA proposes a new plan to streamline updates to…
FDA proposes a new plan to streamline updates to medical devices that use AI
Pharmalittle: FDA approves over-the-counter Narcan; J&J exits the race…
Pharmalittle: FDA approves over-the-counter Narcan; J&J exits the race for the first RSV vaccine
Former J&J exec, an in-demand free agent, takes the…
Former J&J exec, an in-demand free agent, takes the helm at privately held FogPharma

Recommended Stories